本研究旨在筛选与乙肝阳性转移性肝细胞癌相关的基因并揭示其潜在的分子机制。利用GEO数据库中GSE364数据集,筛选在肝内扩散转移组和门静脉癌栓转移组都差异表达的基因,DAVID对差异表达基因进行GO与信号通路富集分析,并用STRING和Cytosc...本研究旨在筛选与乙肝阳性转移性肝细胞癌相关的基因并揭示其潜在的分子机制。利用GEO数据库中GSE364数据集,筛选在肝内扩散转移组和门静脉癌栓转移组都差异表达的基因,DAVID对差异表达基因进行GO与信号通路富集分析,并用STRING和Cytoscape构建蛋白互作网络,随后用mi Rwalk 2.0筛选可能参与肝细胞癌转移的miRNAs,构建miRNA-枢纽基因调控网络。之后使用Smoami R DB 2.0和c Bio Portal分析枢纽基因突变与circRNA和肝细胞癌预后的关系。我们获得在肝内扩散转移组和门静脉癌栓转移组都差异表达的基因701个,富集分析发现这些基因主要涉及血管生成和血管内皮生长因子信号转导等信号通路。从构建的蛋白互作网络中获得参与蛋白互作模式1的15个枢纽基因,GO分析发现其主要参与RNA加工、代谢、剪接等生物过程。构建的miRNA-枢纽基因调控网络中有4个miRNA参与两个枢纽基因的调控,此外肝细胞癌中SRSF1基因有突变并可转录为hsa_circ_0044757,SNRNP200基因突变与患者预后相关。本研究发现的差异表达基因和枢纽基因,有助于我们认识乙肝相关性肝细胞癌转移的分子机制,并可作为新的用于诊断和预后判断的分子标志物。展开更多
AIM: To investigate whether hepatocytes isolated from macroscopically normal liver during hepatic resection for neoplasia could provide a novel source of healthy hepatocytes, including the development of reliable prot...AIM: To investigate whether hepatocytes isolated from macroscopically normal liver during hepatic resection for neoplasia could provide a novel source of healthy hepatocytes, including the development of reliable protocols for malignant cells removal from the hepatocyte preparation. METHODS: Hepatocytes were procured from resected liver of 18 patients with liver tumors using optimised digestion and cell-enrichment protocols. Suspensions of various known quantities of the HT-29 tumor cell line and patient hepatocytes were treated or not with Ep-CAM-antibody-coated immunomagnetic beads in order to investigate the effi cacy of tumor-purging by immunomagnetic depletion, using a semi-quantitative RT-PCR method developed to detect tumor cells. Immunomagnetic bead-treated or bead-untreated tumor cell-hepatocyte suspensions were transplanted intra-peritoneally in Balb/C nude mice to assess the rates of tumor development. RESULTS: Mean viable hepatocyte yield was 9.3 x 106 cells per gram of digested liver with mean viability of 70.5%. Immunomagnetic depletion removed tumor cells to below the RT-PCR detection-threshold of 1 tumor cell in 106 hepatocytes, representing a maximum tumor purging efficacy of greater than 400 000-fold. Transplanted, immunomagnetic bead-purged tumor cell-hepatocyte suspensions did not form peritonealtumors in Balb/C nude mice. Co-transplantation of hepatocytes with tumor cells did not increase tumorigenesis of the tumor cells. CONCLUSION: Immunomagnetic depletion appears to be an effective method of purging contaminating tumor cells to below threshold for likely tumorigenesis. Along with improved techniques for isolation of large numbers of viable hepatocytes, normal liver resected for neoplasia has potential as another clinically useful source of hepatocytes展开更多
Vesicle-based traffi cking of hepatocellular transporters involves delivery of the newly-synthesized carriers from the rough endoplasmic reticulum to either the plasma membrane domain or to an endosomal,submembrane co...Vesicle-based traffi cking of hepatocellular transporters involves delivery of the newly-synthesized carriers from the rough endoplasmic reticulum to either the plasma membrane domain or to an endosomal,submembrane compartment,followed by exocytic targeting to the plasma membrane. Once delivered to the plasma membrane,the transporters usually undergo recycling between the plasma membrane and the endosomal compartment,which usually serves as a reservoir of pre-existing transporters available on demand. The balance between exocytic targeting and endocytic internalization from/to this recycling compartment is therefore a chief determinant of the overall capability of the liver epithelium to secrete bile and to detoxify endo and xenobiotics. Hence,it is a highly regulated process. Impaired regulation of this balance may lead to abnormal localization of these transporters,which results in bile secretory failure due to endocytic internalization of key transporters involved in bile formation. This occurs in several experimental models of hepatocellular cholestasis,and in most human cholestatic liver diseases. This review describes the molecular bases involved in the biology of the dynamic localization of hepatocellular transporters and its regulation,with a focus on the involvement of signaling pathways in this process. Their alterations in different experimental models of cholestasis and in human cholestatic liver disease are reviewed. In addition,the causes explaining the pathological condition (e.g. disorganization of actin or actin-transporter linkers) and the mediators involved (e.g. activation of cholestatic signaling transduction pathways) are also discussed. Finally,several experimental therapeutic approaches based upon the administration of compounds known to stimulate exocytic insertion of canalicular transporters (e.g. cAMP,tauroursodeoxycholate) are described.展开更多
文摘本研究旨在筛选与乙肝阳性转移性肝细胞癌相关的基因并揭示其潜在的分子机制。利用GEO数据库中GSE364数据集,筛选在肝内扩散转移组和门静脉癌栓转移组都差异表达的基因,DAVID对差异表达基因进行GO与信号通路富集分析,并用STRING和Cytoscape构建蛋白互作网络,随后用mi Rwalk 2.0筛选可能参与肝细胞癌转移的miRNAs,构建miRNA-枢纽基因调控网络。之后使用Smoami R DB 2.0和c Bio Portal分析枢纽基因突变与circRNA和肝细胞癌预后的关系。我们获得在肝内扩散转移组和门静脉癌栓转移组都差异表达的基因701个,富集分析发现这些基因主要涉及血管生成和血管内皮生长因子信号转导等信号通路。从构建的蛋白互作网络中获得参与蛋白互作模式1的15个枢纽基因,GO分析发现其主要参与RNA加工、代谢、剪接等生物过程。构建的miRNA-枢纽基因调控网络中有4个miRNA参与两个枢纽基因的调控,此外肝细胞癌中SRSF1基因有突变并可转录为hsa_circ_0044757,SNRNP200基因突变与患者预后相关。本研究发现的差异表达基因和枢纽基因,有助于我们认识乙肝相关性肝细胞癌转移的分子机制,并可作为新的用于诊断和预后判断的分子标志物。
文摘AIM: To investigate whether hepatocytes isolated from macroscopically normal liver during hepatic resection for neoplasia could provide a novel source of healthy hepatocytes, including the development of reliable protocols for malignant cells removal from the hepatocyte preparation. METHODS: Hepatocytes were procured from resected liver of 18 patients with liver tumors using optimised digestion and cell-enrichment protocols. Suspensions of various known quantities of the HT-29 tumor cell line and patient hepatocytes were treated or not with Ep-CAM-antibody-coated immunomagnetic beads in order to investigate the effi cacy of tumor-purging by immunomagnetic depletion, using a semi-quantitative RT-PCR method developed to detect tumor cells. Immunomagnetic bead-treated or bead-untreated tumor cell-hepatocyte suspensions were transplanted intra-peritoneally in Balb/C nude mice to assess the rates of tumor development. RESULTS: Mean viable hepatocyte yield was 9.3 x 106 cells per gram of digested liver with mean viability of 70.5%. Immunomagnetic depletion removed tumor cells to below the RT-PCR detection-threshold of 1 tumor cell in 106 hepatocytes, representing a maximum tumor purging efficacy of greater than 400 000-fold. Transplanted, immunomagnetic bead-purged tumor cell-hepatocyte suspensions did not form peritonealtumors in Balb/C nude mice. Co-transplantation of hepatocytes with tumor cells did not increase tumorigenesis of the tumor cells. CONCLUSION: Immunomagnetic depletion appears to be an effective method of purging contaminating tumor cells to below threshold for likely tumorigenesis. Along with improved techniques for isolation of large numbers of viable hepatocytes, normal liver resected for neoplasia has potential as another clinically useful source of hepatocytes
基金Supported by Grants from CONICET (PIP 6442)Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT PICT 05-26115 and 05-26306),Argentina
文摘Vesicle-based traffi cking of hepatocellular transporters involves delivery of the newly-synthesized carriers from the rough endoplasmic reticulum to either the plasma membrane domain or to an endosomal,submembrane compartment,followed by exocytic targeting to the plasma membrane. Once delivered to the plasma membrane,the transporters usually undergo recycling between the plasma membrane and the endosomal compartment,which usually serves as a reservoir of pre-existing transporters available on demand. The balance between exocytic targeting and endocytic internalization from/to this recycling compartment is therefore a chief determinant of the overall capability of the liver epithelium to secrete bile and to detoxify endo and xenobiotics. Hence,it is a highly regulated process. Impaired regulation of this balance may lead to abnormal localization of these transporters,which results in bile secretory failure due to endocytic internalization of key transporters involved in bile formation. This occurs in several experimental models of hepatocellular cholestasis,and in most human cholestatic liver diseases. This review describes the molecular bases involved in the biology of the dynamic localization of hepatocellular transporters and its regulation,with a focus on the involvement of signaling pathways in this process. Their alterations in different experimental models of cholestasis and in human cholestatic liver disease are reviewed. In addition,the causes explaining the pathological condition (e.g. disorganization of actin or actin-transporter linkers) and the mediators involved (e.g. activation of cholestatic signaling transduction pathways) are also discussed. Finally,several experimental therapeutic approaches based upon the administration of compounds known to stimulate exocytic insertion of canalicular transporters (e.g. cAMP,tauroursodeoxycholate) are described.